PEDIATRICS Vol. 107 No. 4 April 2001, pp. 706-711
Impact of Inhaled Antiinflammatory Therapy on Hospitalization and Emergency Department Visits for Children With Asthma
Received Mar 17, 2000; accepted Aug 3, 2000.
,
, and
From the * Channing Laboratory, Brigham & Women's Hospital,
Harvard Medical School, Boston, Massachusetts; the
Department of
Ambulatory Care and Prevention, Harvard Medical School and Harvard
Pilgrim Health Care, Boston, Massachusetts; the § Center for Health
Studies, Group Health Cooperative of Puget Sound and the Department of
Pediatrics, University of Washington, Seattle, Washington; and the
Center for Health Services Research, Rush Primary Care Institute,
Chicago, Illinois.
Objective. Although the efficacy of inhaled antiinflammatory therapy in improving symptoms and lung function in childhood asthma has been shown in clinical trials, the effectiveness of these medications in real-world practice settings in reducing acute health care use has not been well-evaluated. This study examined the effect of inhaled antiinflammatory therapy on hospitalizations and emergency department (ED) visits by children for asthma.
Design. Defined population cohort study over 1 year.
Setting. Three managed care organizations (MCOs) in Seattle, Boston, and Chicago participating in the Pediatric Asthma Care-Patient Outcome Research and Treatment II trial.
Participants. All 11 195 children, between 3 to 15 years old, with a diagnosis of asthma who were enrolled in the 3 MCOs between July 1996 and June 1997.
Outcome Measures. We identified children with 1 or more asthma diagnoses using automated encounter data. Medication dispensings were identified from automated pharmacy data. Multivariate logistic regression analysis was used to calculate effects of inhaled antiinflammatory therapy on the adjusted relative risk (RR) for hospitalization and ED visits for asthma.
Results. Over 12 months, 217 (1.9%) of children had an
asthma hospitalization, and 757 (6.8%) had an ED visit. After
adjustment for age, gender, MCO, and reliever dispensing, compared with
children who did not receive controllers, the adjusted RRs for an ED
visit were: children with any (
1) dispensing of cromolyn, 0.4 (95% confidence interval [CI]: 0.3, 0.5); any inhaled corticosteroid (ICS), 0.5 (95% CI: 0.4, 0.6); any cromolyn or ICS combined (any controller), 0.4 (95% CI: 0.3, 0.5). For hospitalization, the adjusted
RR for cromolyn was 0.6 (95% CI: 0.4, 0.9), for ICS 0.4 (95% CI: 0.3, 0.7), and for any controller 0.4 (95% CI: 0.3, 0.6). A significant
protective effect for both events was seen among children with 1 to 5 and with >5 antiinflammatory dispensings. When the analysis was
stratified by frequency of reliever dispensing, there was a significant
protective effect for controllers on ED visits for children with 1 to 5 and with >5 reliever dispensings and on the risk of hospitalization
for children with >5 reliever dispensings.
Conclusions. Inhaled antiinflammatory therapy is associated with a significant protective effect on the risk for hospitalization and ED visits in children with asthma. Cromolyn and ICSs were associated with similar effects on risks.asthma drug therapy, inhaled antiinflammatory agents, health maintenance organizations, hospitalization, emergency department. .
This article has been cited by other articles:
![]() |
J. J. Zorc, A. Chew, J. L. Allen, and K. Shaw Beliefs and Barriers to Follow-up After an Emergency Department Asthma Visit: A Randomized Trial Pediatrics, October 1, 2009; 124(4): 1135 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lasmar, P. Camargos, J. Bousquet, E. Goulart, E. Sakurai, and M. Carvalhais Factors Related to Lower Adherence Rates to Inhaled Corticosteroids in Children and Adolescents: A Prospective Randomized Cohort Study J Trop Pediatr, February 1, 2009; 55(1): 20 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Gerald, L. A. McClure, J. M. Mangan, K. F. Harrington, L. Gibson, S. Erwin, J. Atchison, and R. Grad Increasing Adherence to Inhaled Steroid Therapy Among Schoolchildren: Randomized, Controlled Trial of School-Based Supervised Asthma Therapy Pediatrics, February 1, 2009; 123(2): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Nkoy, B. A. Fassl, T. D. Simon, B. L. Stone, R. Srivastava, P. H. Gesteland, G. M. Fletcher, and C. G. Maloney Quality of Care for Children Hospitalized With Asthma Pediatrics, November 1, 2008; 122(5): 1055 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suissa Immortal Time Bias in Pharmacoepidemiology Am. J. Epidemiol., February 15, 2008; 167(4): 492 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mangione-Smith, A. H. DeCristofaro, C. M. Setodji, J. Keesey, D. J. Klein, J. L. Adams, M. A. Schuster, and E. A. McGlynn The Quality of Ambulatory Care Delivered to Children in the United States N. Engl. J. Med., October 11, 2007; 357(15): 1515 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Brousseau, R. G. Hoffmann, A. B. Nattinger, G. Flores, Y. Zhang, and M. Gorelick Quality of Primary Care and Subsequent Pediatric Emergency Department Utilization Pediatrics, June 1, 2007; 119(6): 1131 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Camargo Jr., S. Ramachandran, K. L. Ryskina, B. E. Lewis, and A. P. Legorreta Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan Am. J. Health Syst. Pharm., May 15, 2007; 64(10): 1054 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Lehman, K. A. Lillis, S. H. Shaha, M. Augustine, and M. Ballow Initiation of Maintenance Antiinflammatory Medication in Asthmatic Children in a Pediatric Emergency Department Pediatrics, December 1, 2006; 118(6): 2394 - 2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Fuhlbrigge, T. Guilbert, J. Spahn, D. Peden, and K. Davis The Influence of Variation in Type and Pattern of Symptoms on Assessment in Pediatric Asthma Pediatrics, August 1, 2006; 118(2): 619 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schuh, P. T. Dick, D. Stephens, M. Hartley, S. Khaikin, L. Rodrigues, and A. L. Coates High-Dose Inhaled Fluticasone Does Not Replace Oral Prednisolone in Children With Mild to Moderate Acute Asthma Pediatrics, August 1, 2006; 118(2): 644 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Teach, E. F. Crain, D. M. Quint, M. L. Hylan, and J. G. Joseph Improved Asthma Outcomes in a High-Morbidity Pediatric Population: Results of an Emergency Department-Based Randomized Clinical Trial Arch Pediatr Adolesc Med, May 1, 2006; 160(5): 535 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Galant, T. Morphew, S. Amaro, and O. Liao Current Asthma Guidelines May Not Identify Young Children Who Have Experienced Significant Morbidity Pediatrics, April 1, 2006; 117(4): 1038 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Teach, M. F. Guagliardo, E. F. Crain, R. J. McCarter, D. M. Quint, C. Shao, and J. G. Joseph Spatial Accessibility of Primary Care Pediatric Services in an Urban Environment: Association With Asthma Management and Outcome. Pediatrics, April 1, 2006; 117(4 Pt 2): S78 - S85. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Scarfone, J. J. Zorc, and C. J. Angsuco Emergency Physicians' Prescribing of Asthma Controller Medications Pediatrics, March 1, 2006; 117(3): 821 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Porter, P. Forbes, H. A. Feldman, and D. A. Goldmann Impact of Patient-Centered Decision Support on Quality of Asthma Care in the Emergency Department Pediatrics, January 1, 2006; 117(1): e33 - e42. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Senthilselvan, J. A. Lawson, D. C. Rennie, and J. A. Dosman Regular Use of Corticosteroids and Low Use of Short-Acting {beta}2-Agonists Can Reduce Asthma Hospitalization Chest, April 1, 2005; 127(4): 1242 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Galant, L. J.R. Crawford, T. Morphew, C. A. Jones, and S. Bassin Predictive Value of a Cross-Cultural Asthma Case-Detection Tool in an Elementary School Population Pediatrics, September 1, 2004; 114(3): e307 - e316. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.W.A. Kamps, R.J. Roorda, J.L.L. Kimpen, A.W. Overgoor-van de Groes, L.C.J.A.M. van Helsdingen-Peek, and P.L.P. Brand Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs Eur. Respir. J., February 1, 2004; 23(2): 304 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rachelefsky Treating Exacerbations of Asthma in Children: The Role of Systemic Corticosteroids Pediatrics, August 1, 2003; 112(2): 382 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Bloomberg, K. M. Trinkaus, E. B. Fisher Jr., J. R. Musick, and R. C. Strunk Hospital Readmissions for Childhood Asthma: A 10-Year Metropolitan Study Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1068 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Zorc, R. J. Scarfone, Y. Li, T. Hong, M. Harmelin, L. Grunstein, and J. B. Andre Scheduled Follow-up After a Pediatric Emergency Department Visit for Asthma: A Randomized Trial Pediatrics, March 1, 2003; 111(3): 495 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Soussan, R Liard, M Zureik, D Touron, Y Rogeaux, and F Neukirch Treatment compliance, passive smoking, and asthma control: a three year cohort study Arch. Dis. Child., March 1, 2003; 88(3): 229 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Korhonen, T.M. Reijonen, K. Malmstrom, T. Klaukka, K. Remes, and M. Korppi Hospitalization trends for paediatric asthma in eastern Finland: a 10-yr survey Eur. Respir. J., June 1, 2002; 19(6): 1035 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Finkelstein, P. Lozano, H. J. Farber, I. Miroshnik, and T. A. Lieu Underuse of Controller Medications Among Medicaid-Insured Children With Asthma Arch Pediatr Adolesc Med, June 1, 2002; 156(6): 562 - 567. [Abstract] [Full Text] [PDF] |
||||















